Our Team

Francesca Fox

  • With over a decade of leadership experience, Francesca Fox has driven NEWAVX to profitability since its inception, achieving 60% year-on-year growth. A visionary in commercialising cutting-edge technology, she has led the company’s global expansion, establishing strategic partnerships with major industry players, including top insurance providers.

    Francesca is committed to empowering teams and fostering inclusive innovation, underpinned by her personal journey with dyslexia. This leadership style has propelled NEWAVX into new frontiers, solidifying its position as a pioneer in the intersection of space tech, health tech, and deep tech. Her strategic foresight continues to drive the company toward its next phase of transformative impact in human health, space health, and pharmaceutical breakthroughs.

Co-Founder & CEO, NEWAVX

Dominic Fox

  • With over 15 years of experience in professional sports, Dominic Fox co-founded NEWAVX, applying his extensive knowledge of elite athlete needs, injury recovery, and physiotherapy. As Chief Operations Officer, he has played a pivotal role in global expansion, launching VWC therapy products across five countries and securing a £350,000 deal for a world-ranking event in the UAE.

    Dominic’s leadership has been instrumental in securing a £150,000 Innovate UK grant for a groundbreaking project with the University of Birmingham, further driving innovation in healthcare solutions. Passionate about ESG values, he champions sustainability and positive impact, ensuring that NEWAVX’s mission aligns with responsible business practices and delivers long-term societal benefits.

Co-Founder & COO, NEWAVX

Dr. Rebecca Marchmont

Chief Clinical Advisor & Lead Safeguarding GP, NEWAVX

  • Dr. Rebecca Marchmont brings over a decade of expertise in geriatrics and dementia care. As NEWAVX’s Chief Clinical Advisor, she ensures our health solutions are ethically grounded and patient-centered, while driving integrated care initiatives. Her focus on non-pharmaceutical approaches and reducing opioid reliance positions NEWAVX at the forefront of innovative, scalable healthcare solutions for aging populations. Dr. Marchmont’s leadership is instrumental in aligning our technolog􀁌 with real-world clinical needs, paving the way for impactful, sustainable growth in the healthcare market.

Prof. David Smith & Prof. Leigh Breen

Chief Mathematician & Head of Innovation, NEWAVX

  • Prof. David Smith and Prof. Leigh Breen lead the scientific and clinical direction at NEWAVX. Prof. Smith, as Chief Mathematician, develops the advanced mathematical models and fluid dynamics equations that form the foundation of our health technologies. Prof. Breen, as Head of Innovation, applies these innovations in real-world settings, from space health to metabolic diseases. Together, they ensure our breakthroughs are scientifically robust and clinically impactful, advancing health solutions for both Earth and space.

University of Birmingham 

University of Birmingham:
A Leader in Research Excellence

The University of Birmingham is consistently ranked 6th in the UK and is renowned for its commitment to research excellence and innovative teaching. As a proud member of the Russell Group, the University plays a pivotal role in shaping higher education while addressing pressing global challenges. Our interdisciplinary approach fosters collaboration across diverse fields of study, driving groundbreaking research that impacts society significantly.

Left to right  — Prof Leigh Breen, Dr Jonathan Quinlan, Francesca Fox, Dominic Fox & Dr Alex Wadley

School of Sport, Exercise and Rehabilitation Sciences

At the forefront of this innovative research is the School of Sport, Exercise and Rehabilitation Sciences, celebrated as a hub for cutting-edge studies that advance human health and performance. Under the leadership of notable experts, including Professor Leigh Breen, the School investigates the intricate relationships between exercise, nutrition, and physical well-being.

Together, we are dedicated to promoting health equity and enhancing outcomes for individuals across diverse populations. By leveraging the University of Birmingham’s robust research environment and extensive partnerships with healthcare organisations and industry leaders, we are well-positioned to drive transformative initiatives aimed at improving the quality of life for communities both locally and globally.

For more detailed information on our research and its implications, please visit our project page: Understanding the Musculoskeletal and Physiological Effects of VO.
Together, we are dedicated to advancing the understanding of health and well-being, fostering innovations that will drive meaningful change both locally and globally.